Pharmacological inhibition of the ataxia telangiectasia and Rad3-similar protein serine/threonine kinase (ATR; generally known as FRAP-related protein (FRP1)) has emerged as a promising system for cancer remedy that exploits artificial lethal interactions with proteins linked to DNA injury fix, overcomes resistance to other therapies and boosts antitumour immunity. Multiple novel, https://jacquesr998epz1.blogdiloz.com/profile